SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genaissance Pharmaceuticals (GNSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (6)11/3/2000 9:32:16 PM
From: Jim Oravetz  Read Replies (2) of 183
 
Call replay: In conjunction with the release of its financial results for
the third quarter ended September 30, 2000, Gualberto Ruano, M.D., Ph.D., Chief Executive Officer of
Genaissance Pharmaceuticals (Nasdaq: GNSC, news, msgs), will conduct a conference call:

Thursday, November 2, 2000
11:00 a.m. Eastern

To participate in this call,
dial: 913-981-5549
confirmation code: 535629
shortly before 11:00 a.m. Eastern

To reserve a line,
please call Rhonda Chiger at Nexus Communications Group, LLC
917-322-2569.

A replay of the call will be available from 2:00 p.m. Eastern through midnight Thursday, November 9th.
The replay number is 719-457-0820.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext